Correction to Selective Class I Phosphoinositide 3-Kinase Inhibitors

Oct 12, 2012 - Mark H. Norman,* Kristin L. Andrews, Yunxin Y. Bo, Shon K. Booker, Sean Caenepeel, Victor J. Cee,. Noel D. D'Angelo, Daniel J. Freeman,...
0 downloads 0 Views 112KB Size
Addition/Correction pubs.acs.org/jmc

Correction to Selective Class I Phosphoinositide 3‑Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511 Mark H. Norman,* Kristin L. Andrews, Yunxin Y. Bo, Shon K. Booker, Sean Caenepeel, Victor J. Cee, Noel D. D’Angelo, Daniel J. Freeman, Bradley J. Herberich, Fang-Tsao Hong, Claire L. M. Jackson, Jian Jiang, Brian A. Lanman, Longbin Liu, John D. McCarter, Erin L. Mullady, Nobuko Nishimura, Liping H. Pettus, Anthony B. Reed, Tisha San Miguel, Adrian L. Smith, Markian M. Stec, Seifu Tadesse, Andrew Tasker, Divesh Aidasani, Xiaochun Zhu, Raju Subramanian, Nuria A. Tamayo, Ling Wang, Douglas A. Whittington, Bin Wu, Tian Wu, Ryan P. Wurz, Kevin Yang, Leeanne Zalameda, Nancy Zhang, and Paul E. Hughes Journal of Medicinal Chemistry 2012, 55, 7796−7816. DOI: 10.1021/jm300846z Page 7809. In the right column, line 14, the designation should be “(S)” instead of “(R)”. Page 7809. In the right column, line 23, the designation should be “(R)” instead of “(S)”.

Published: October 12, 2012 © 2012 American Chemical Society

8975

dx.doi.org/10.1021/jm301439j | J. Med. Chem. 2012, 55, 8975−8975